News

Then, we're going to make that even easier for physicians with hopefully an approval in August for the subcutaneous formulation ... administration with an auto injector. And of course, in the ...
The antibody lecanemab is the first authorized therapy in Europe that targets the underlying process of Alzheimer's, rather than only treating symptoms. The European Commission announced on ...
Earlier this year, the FDA accepted Eisai and Biogen’s Biologics License Application (BLA) for lecanemab subcutaneous autoinjector for weekly maintenance dosing. A Prescription Drug User Fee Act ...
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) ...
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early ...
In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD) ...
A resident of a nursing home plays the game "Memory" on a care ward and puts pairs of cards together. The European Commission has approved the antibody lecanemab to treat Alzheimer's, the first ...
Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat under the skin. These subcutaneous medications include ...
(MENAFN- JCN NewsWire) Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union In the European Union (EU), lecanemab is ...
Eisai Co., Ltd. and Biogen Inc. announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as a treatment ... for the Leqembi subcutaneous ...
VYVGART for subcutaneous injection is available as a vial or prefilled syringe and can be administered by a patient, caregiver, or healthcare professional. Treatment is initiated with a weekly dose ...
WASHINGTON — President Donald Trump signed executive orders Tuesday to relax some of his 25% tariffs on automobiles and auto parts, the White House said, a significant reversal as the import ...